Tuesday, April 21, 2020

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Enabling Patients to Access Physicians from Home


Trxade Group’s (NASDAQ: MEDS) wholly owned subsidiary Bonum Health is a virtual telehealth provider that is helping patients to simply and affordably access board-certified physicians and receive medical prescriptions from the comfort of their homes. A recent article discussing the company reads, “On March 4, 2020, Congress approved an $8.3 billion package (http://ibn.fm/G8r6e) in emergency aid to combat the novel coronavirus, which included provisions for Medicare providers to administer telehealth services so that elderly patients, a particularly vulnerable demographic, could receive care at home. The aid package was summarily followed by a coalition of private health insurers, who after a meeting at the White House on March 10, 2020, stated that they would pay for ‘virtual visits’ for patients who may have coronavirus so as to improve access to care for their customers (http://ibn.fm/QK8pG). . . .  In light of the news, Trxade Group is leveraging upon Bonum Health’s unique healthcare platform to assist their members in gaining medical assurance in a quick, easy and relatively inexpensive manner. ‘With the seasonal flu outbreaks and the current coronavirus surge, patients are quick to brush off common symptoms, including cough, fever and body aches, as signs of a common cold,’ Trxade Group’s news release states. ‘Telemedicine removes the barrier of self-doubt and complacency in the current climate of worldwide viral infections.’ In an effort to further increase accessibility to their services, Trxade Group announced the recent launch of a new membership service from Bonum Health on March 10, 2020. The new service would allow subscribers to obtain three premium medical-teleconferencing visits and free prescription delivery per month (http://ibn.fm/SFeSY).”

To view the full article, visit http://ibn.fm/wilOc

About Trxade Group Inc.

Headquartered in Tampa, Florida, Trxade is an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same-day or mail-order pharmacy delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For more information, visit the company’s websites at www.Trxade.comwww.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html